XTLB XTL Biopharmaceuticals Ltd Net earnings per share growth forecast for next year
The GURU.Markets terminal provides a chart of the expected EPS change for next year, where the current mark is 0.00. Stable laboratory operations ensure uninterrupted drug testing. The growth in XTL Biopharmaceuticals (XTLB) capitalization is based on the advancement of autoimmune pathology therapies and liquidity. Financial success relies on licensing agreements for the treatment of cancer and lupus, which will generate future royalties.
Financial and market metric breakdowns for XTL Biopharmaceuticals Ltd (XTLB)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio XTL Biopharmaceuticals|XTLB - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity XTL Biopharmaceuticals, Ltd.|XTLB - Company Debts|Debt to Book Value XTL Biopharmaceuticals, Ltd.|XTLB - Company Long-Term Loans and Borrowings|Company Short-Term Debts XTL Biopharmaceuticals|Quick Ratio xtlbio.com
- earnings and valuation multiples information:
XTLB - Net Financial Result|Expected Profit XTL Biopharmaceuticals|XTLB - Market Cap to Earnings|Future Price to Earnings XTL Biopharmaceuticals|XTLB - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple XTL Biopharmaceuticals, Ltd.|XTLB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) XTL Biopharmaceuticals|XTLB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months xtlbio.com|XTLB - Earnings per share increase in current year|Net earnings per share growth forecast for next year XTL Biopharmaceuticals
- total revenue and sales volume data:
Summary company analysis:XTL Biopharmaceuticals
This indicator measures the analysts' consensus forecast for changes in earnings per share, determining the asset's future investment attractiveness. The trend in expected net income changes visualizes market expectations, allowing investors to assess the risk of capital drawdown during a cycle shift. Growth in this metric confirms the efficiency of bioinformatics protein analysis automation, which reduces manual labor in XTL Biopharmaceuticals (XTLB) laboratories and accelerates drug development.
Competitor analysis for XTL Biopharmaceuticals
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ikenaoncology.com (IMA) - Expected earnings per share growth for next year|Shattuck Labs (STTK) - Net earnings per share growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|CNTB (connectbiopharm.com) - Earnings growth forecast for next year|IMUX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Atara Biotherapeutics, Inc. (ATRA)|Consensus forecast of earnings per share growth for next year InflaRx NV|Earnings growth forecast for next year XFOR (X4 Pharmaceuticals)|Earnings growth forecast for next year Adicet Bio ACET|CELU: Expected earnings per share growth for next year|Expected earnings per share trend next year INMB (INmune Bio)|Barinthus Bio (BRNS) - Net earnings per share growth forecast for next year|Kezar Life Sciences (KZR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year sabbiotherapeutics.com|Earnings growth forecast for next year Akari Therapeutics Plc|Net earnings per share growth forecast for next year Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year GeoVax Corp GOVX|Consensus forecast of earnings per share growth for next year Edesa Biotech Corp (EDSA)|IBIO: Expected earnings per share growth for next year|Expected earnings per share trend next year CARM (carismatx.com)|BOLT: Earnings growth forecast for next year|Expected earnings per share growth for next year HCW Biologics Inc.|Net earnings per share growth forecast for next year aptevotherapeutics.com|AIM: Expected earnings per share trend next year|Net earnings per share growth forecast for next year aditxt.com (ADTX)|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Expected net earnings per share growth next year|REVB - Net earnings per share growth forecast for next year|INDP - Earnings growth forecast for next year|SCNI: Earnings growth forecast for next year|Expected earnings per share growth for next year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth forecast for next year|allakos.com (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
